🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
211.40
-1.30 (-0.61%)
Nov 20, 2026, 11:00 AM CET

Zealand Pharma Statistics

Total Valuation

Zealand Pharma has a market cap or net worth of DKK 14.13 billion. The enterprise value is 1.10 billion.

Market Cap14.13B
Enterprise Value 1.10B

Important Dates

The last earnings date was Thursday, November 12, 2026.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

Zealand Pharma has 66.84 million shares outstanding. The number of shares has decreased by -1.14% in one year.

Current Share Class 66.84M
Shares Outstanding 66.84M
Shares Change (YoY) -1.14%
Shares Change (QoQ) -3.43%
Owned by Insiders (%) 0.26%
Owned by Institutions (%) 27.22%
Float 57.03M

Valuation Ratios

The trailing PE ratio is 4.83.

PE Ratio 4.83
Forward PE n/a
PS Ratio 3.09
PB Ratio 0.82
P/TBV Ratio 0.88
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.39
EV / Sales 0.26
EV / EBITDA 0.43
EV / EBIT 0.44
EV / FCF n/a

Financial Position

The company has a current ratio of 10.50, with a Debt / Equity ratio of 0.03.

Current Ratio 10.50
Quick Ratio 10.36
Debt / Equity 0.03
Debt / EBITDA 0.18
Debt / FCF n/a
Interest Coverage 93.40

Financial Efficiency

Return on equity (ROE) is 19.07% and return on invested capital (ROIC) is 64.14%.

Return on Equity (ROE) 19.07%
Return on Assets (ROA) 9.36%
Return on Invested Capital (ROIC) 64.14%
Return on Capital Employed (ROCE) 15.31%
Weighted Average Cost of Capital (WACC) 6.78%
Revenue Per Employee 7.60M
Profits Per Employee 5.11M
Employee Count605
Asset Turnover 0.25
Inventory Turnover n/a

Taxes

In the past 12 months, Zealand Pharma has paid 113.06 million in taxes.

Income Tax 113.06M
Effective Tax Rate 3.53%

Stock Price Statistics

The stock price has decreased by -58.63% in the last 52 weeks. The beta is 0.47, so Zealand Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.47
52-Week Price Change -58.63%
50-Day Moving Average 245.78
200-Day Moving Average 295.85
Relative Strength Index (RSI) 29.89
Average Volume (20 Days) 397,750

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Zealand Pharma had revenue of DKK 4.60 billion and earned 3.09 billion in profits. Earnings per share was 43.77.

Revenue4.60B
Gross Profit 4.60B
Operating Income 2.71B
Pretax Income 3.20B
Net Income 3.09B
EBITDA 2.74B
EBIT 2.71B
Earnings Per Share (EPS) 43.77
Full Income Statement

Balance Sheet

The company has 13.51 billion in cash and 484.00 million in debt, with a net cash position of 13.03 billion or 194.88 per share.

Cash & Cash Equivalents 13.51B
Total Debt 484.00M
Net Cash 13.03B
Net Cash Per Share 194.88
Equity (Book Value) 17.24B
Book Value Per Share 257.88
Working Capital 16.26B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.48 billion and capital expenditures -51.37 million, giving a free cash flow of -1.53 billion.

Operating Cash Flow -1.48B
Capital Expenditures -51.37M
Depreciation & Amortization 20.95M
Net Borrowing -31.16M
Free Cash Flow -1.53B
FCF Per Share -22.94
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 59.03% and 67.21%.

Gross Margin 100.00%
Operating Margin 59.03%
Pretax Margin 69.66%
Profit Margin 67.21%
EBITDA Margin 59.49%
EBIT Margin 59.03%
FCF Margin n/a

Dividends & Yields

Zealand Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield 1.14%
Shareholder Yield 1.14%
Earnings Yield 20.71%
FCF Yield -10.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside
Graham Formula Value n/a
Graham Formula Upside n/a

Analyst Forecast

The average price target for Zealand Pharma is 383.58, which is 81.45% higher than the current price. The consensus rating is "Buy".

Price Target 383.58
Price Target Difference 81.45%
Analyst Consensus Buy
Analyst Count 16
Revenue Growth Forecast (3Y) -42.16%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Zealand Pharma has an Altman Z-Score of 8.84 and a Piotroski F-Score of 3.

Altman Z-Score 8.84
Piotroski F-Score 3